SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-002262
Filing Date
2017-03-31
Accepted
2017-03-31 16:30:39
Documents
15
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231451z10-k.htm 10-K 1376696
2 EX-4.4 a2231451zex-4_4.htm EX-4.4 101796
3 EX-10.2 a2231451zex-10_2.htm EX-10.2 95033
4 EX-10.26 a2231451zex-10_26.htm EX-10.26 338128
5 EX-10.27 a2231451zex-10_27.htm EX-10.27 25639
6 EX-10.28 a2231451zex-10_28.htm EX-10.28 35835
7 EX-10.29 a2231451zex-10_29.htm EX-10.29 55044
8 EX-21.1 a2231451zex-21_1.htm EX-21.1 4311
9 EX-23.1 a2231451zex-23_1.htm EX-23.1 2575
10 EX-31.1 a2231451zex-31_1.htm EX-31.1 7811
11 EX-31.2 a2231451zex-31_2.htm EX-31.2 7783
12 EX-32.1 a2231451zex-32_1.htm EX-32.1 5890
13 G345365.JPG g345365.jpg GRAPHIC 60814
14 G788212.JPG g788212.jpg GRAPHIC 35463
15 G86102LK11I001.GIF g86102lk11i001.gif GRAPHIC 81326
  Complete submission text file 0001047469-17-002262.txt   2302661
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37990 | Film No.: 17730781
SIC: 2834 Pharmaceutical Preparations